Effect of once-daily, modified-release hydrocortisone vs standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): A single-blind, randomised controlled trial
The Lancet Diabetes & Endocrinology Mar 02, 2018
Isidori AM, et al. - Researchers here sought to demonstrate if the timing and pharmacokinetics of glucocorticoid replacement therapy affect the metabolism and immune system of patients with adrenal insufficiency. Observations revealed a pro-inflammatory state and weakened immune defense among patients with adrenal insufficiency on conventional glucocorticoid replacement therapy multiple times a day. In patients with adrenal insufficiency, restoration of a more physiological circadian glucocorticoid rhythm by switching to a once-daily, modified-release regimen reduced bodyweight, normalized the immune cell profile, reduced recurrent infections, and improved the quality of life.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries